Artículos de revistas sobre el tema "LL-37 peptid"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "LL-37 peptid".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Guo, Fang-Fang y Jing-Yuan Fang. "Antimicrobial peptide LL-37 and gastrointestinal diseases". World Chinese Journal of Digestology 22, n.º 35 (2014): 5454. http://dx.doi.org/10.11569/wcjd.v22.i35.5454.
Bucki, Robert, Katarzyna Leszczyńska, Andrzej Namiot y Wojciech Sokołowski. "Cathelicidin LL-37: A Multitask Antimicrobial Peptide". Archivum Immunologiae et Therapiae Experimentalis 58, n.º 1 (5 de enero de 2010): 15–25. http://dx.doi.org/10.1007/s00005-009-0057-2.
Rapala-Kozik, Maria, Oliwia Bochenska, Marcin Zawrotniak, Natalia Wolak, Grzegorz Trebacz, Mariusz Gogol, Dominika Ostrowska, Wataru Aoki, Mitsuyoshi Ueda y Andrzej Kozik. "Inactivation of the Antifungal and Immunomodulatory Properties of Human Cathelicidin LL-37 by Aspartic Proteases Produced by the Pathogenic Yeast Candida albicans". Infection and Immunity 83, n.º 6 (6 de abril de 2015): 2518–30. http://dx.doi.org/10.1128/iai.00023-15.
Sieprawska-Lupa, Magdalena, Piotr Mydel, Katarzyna Krawczyk, Kinga Wójcik, Magdalena Puklo, Boguslaw Lupa, Piotr Suder et al. "Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus-Derived Proteinases". Antimicrobial Agents and Chemotherapy 48, n.º 12 (diciembre de 2004): 4673–79. http://dx.doi.org/10.1128/aac.48.12.4673-4679.2004.
Martynowycz, Michael, Amy Rice, Konstantin Andreev, Thatyane M. Nobre Pavinatto, Jeff Wereszczynski y David Gidalevitz. "Interaction of Antimicrobial Peptide Ll-37 with Lipopolysaccharides". Biophysical Journal 116, n.º 3 (febrero de 2019): 45a. http://dx.doi.org/10.1016/j.bpj.2018.11.285.
Yusuf, Muhammad, Wanda Destiarani, Ade Rizqi Ridwan Firdaus, Fauzian Giansyah Rohmatulloh, Mia Tria Novianti, Gita Widya Pradini y Reiva Farah Dwiyana. "Residual Interactions of LL-37 with POPC and POPE:POPG Bilayer Model Studied by All-Atom Molecular Dynamics Simulation". International Journal of Molecular Sciences 23, n.º 21 (2 de noviembre de 2022): 13413. http://dx.doi.org/10.3390/ijms232113413.
Zhao, Chengquan, Tung Nguyen, Lee Ming Boo, Teresa Hong, Cesar Espiritu, Dmitri Orlov, Wei Wang, Alan Waring y Robert I. Lehrer. "RL-37, an Alpha-Helical Antimicrobial Peptide of the Rhesus Monkey". Antimicrobial Agents and Chemotherapy 45, n.º 10 (1 de octubre de 2001): 2695–702. http://dx.doi.org/10.1128/aac.45.10.2695-2702.2001.
Bals, Robert, Xiaorong Wang, Michael Zasloff y James M. Wilson. "The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface". Proceedings of the National Academy of Sciences 95, n.º 16 (4 de agosto de 1998): 9541–46. http://dx.doi.org/10.1073/pnas.95.16.9541.
Ishvaanjil, Bayartbat, Yu-Jin Jung, Uyangaa Temuujin, Soon-Youl Lee y Kwon-Kyoo Kang. "HETEROLOGOUS EXPRESSION OF ANTIMICROBIAL PEPTIDE LL-37 IN CHINESE CABBAGE WITH ENHANCED RESISTANCE TO PATHOGENS". Mongolian Journal of Agricultural Sciences 13, n.º 2 (22 de junio de 2015): 124–30. http://dx.doi.org/10.5564/mjas.v13i2.531.
Ridyard, Kylen E. y Joerg Overhage. "The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent". Antibiotics 10, n.º 6 (29 de mayo de 2021): 650. http://dx.doi.org/10.3390/antibiotics10060650.
Rinker, Sherri D., Michael P. Trombley, Xiaoping Gu, Kate R. Fortney y Margaret E. Bauer. "Deletion ofmtrCin Haemophilus ducreyi Increases Sensitivity to Human Antimicrobial Peptides and Activates the CpxRA Regulon". Infection and Immunity 79, n.º 6 (28 de marzo de 2011): 2324–34. http://dx.doi.org/10.1128/iai.01316-10.
Qin, G. T., A. Lopez, C. Santos, A. M. McDermott y C. Z. Cai. "Antimicrobial peptide LL-37 on surfaces presenting carboxylate anions". Biomaterials Science 3, n.º 5 (2015): 771–78. http://dx.doi.org/10.1039/c5bm00055f.
Torossian, Alexander, Eugeniu Gurschi, Robert Bals, Timon Vassiliou, Hinnerk F. Wulf y Artur Bauhofer. "Effects of the Antimicrobial Peptide LL-37 and Hyperthermic Preconditioning in Septic Rats". Anesthesiology 107, n.º 3 (1 de septiembre de 2007): 437–41. http://dx.doi.org/10.1097/01.anes.0000278906.86815.eb.
Perez-Perez, David A., Teresa de J. Villanueva-Ramirez, Adriana E. Hernandez-Pedraza, Nestor G. Casillas-Vega, Patricia Gonzalez-Barranco y Xristo Zarate. "The Small Metal-Binding Protein SmbP Simplifies the Recombinant Expression and Purification of the Antimicrobial Peptide LL-37". Antibiotics 10, n.º 10 (19 de octubre de 2021): 1271. http://dx.doi.org/10.3390/antibiotics10101271.
McCrudden, Maelíosa, Katherine O’Donnell, Chris Irwin y Fionnuala Lundy. "Effects of LL-37 on Gingival Fibroblasts: A Role in Periodontal Tissue Remodeling?" Vaccines 6, n.º 3 (23 de julio de 2018): 44. http://dx.doi.org/10.3390/vaccines6030044.
Sigurdardottir, Thorgerdur, Pia Andersson, Mina Davoudi, Martin Malmsten, Artur Schmidtchen y Mikael Bodelsson. "In Silico Identification and Biological Evaluation of Antimicrobial Peptides Based on Human Cathelicidin LL-37". Antimicrobial Agents and Chemotherapy 50, n.º 9 (septiembre de 2006): 2983–89. http://dx.doi.org/10.1128/aac.01583-05.
Yang, De, Qian Chen, Albert P. Schmidt, G. Mark Anderson, Ji Ming Wang, Joseph Wooters, Joost J. Oppenheim y Oleg Chertov. "Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells". Journal of Experimental Medicine 192, n.º 7 (2 de octubre de 2000): 1069–74. http://dx.doi.org/10.1084/jem.192.7.1069.
Byfield, Fitzroy J., Qi Wen, Katarzyna Leszczyńska, Alina Kułakowska, Zbigniew Namiot, Paul A. Janmey y Robert Bucki. "Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability". American Journal of Physiology-Cell Physiology 300, n.º 1 (enero de 2011): C105—C112. http://dx.doi.org/10.1152/ajpcell.00158.2010.
Peter Bergman, Lilian Walter-Jallow, Kristina Broliden, Birgitta Agerberth y Johan Soderlund. "The Antimicrobial Peptide LL-37 Inhibits HIV-1 Replication". Current HIV Research 5, n.º 4 (1 de julio de 2007): 410–15. http://dx.doi.org/10.2174/157016207781023947.
Supanchart, C., S. Thawanaphong, A. Makeudom, J. G. Bolscher, K. Nazmi, U. Kornak y S. Krisanaprakornkit. "The Antimicrobial Peptide, LL-37, Inhibits in vitro Osteoclastogenesis". Journal of Dental Research 91, n.º 11 (13 de septiembre de 2012): 1071–77. http://dx.doi.org/10.1177/0022034512460402.
Srakaew, Nopparat, Charlene Young, Krista Quesnel, Hongbin Xu, Riccardo di Brisco, Duriya Fongmoon, Greanggrai Hommalai et al. "Antimicrobial Peptide, LL-37, as a Potential Vaginal Contraceptive." Biology of Reproduction 87, Suppl_1 (1 de agosto de 2012): 357. http://dx.doi.org/10.1093/biolreprod/87.s1.357.
Fabisiak, Adam, Natalia Murawska y Jakub Fichna. "LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity". Pharmacological Reports 68, n.º 4 (agosto de 2016): 802–8. http://dx.doi.org/10.1016/j.pharep.2016.03.015.
Lee, Chang-Chun, Yen Sun, Chih-Wei Chen, Shuo Qian y Huey W. Huang. "Transmembrane Pores Formed by Human Antimicrobial Peptide LL-37". Biophysical Journal 100, n.º 3 (febrero de 2011): 336a. http://dx.doi.org/10.1016/j.bpj.2010.12.2039.
Lee, Chang-Chun, Yen Sun, Shuo Qian y Huey W. Huang. "Transmembrane Pores Formed by Human Antimicrobial Peptide LL-37". Biophysical Journal 100, n.º 7 (abril de 2011): 1688–96. http://dx.doi.org/10.1016/j.bpj.2011.02.018.
Lee, Moonhee, Xiaolei Shi, Annelise E. Barron, Edith McGeer y Patrick L. McGeer. "Human antimicrobial peptide LL-37 induces glial-mediated neuroinflammation". Biochemical Pharmacology 94, n.º 2 (marzo de 2015): 130–41. http://dx.doi.org/10.1016/j.bcp.2015.02.003.
Zsila, Ferenc y Tamás Beke-Somfai. "Human host-defense peptide LL-37 targets stealth siderophores". Biochemical and Biophysical Research Communications 526, n.º 3 (junio de 2020): 780–85. http://dx.doi.org/10.1016/j.bbrc.2020.03.162.
Nagant, C., B. Pitts, K. Nazmi, M. Vandenbranden, J. G. Bolscher, P. S. Stewart y J. P. Dehaye. "Identification of Peptides Derived from the Human Antimicrobial Peptide LL-37 Active against Biofilms Formed by Pseudomonas aeruginosa Using a Library of Truncated Fragments". Antimicrobial Agents and Chemotherapy 56, n.º 11 (20 de agosto de 2012): 5698–708. http://dx.doi.org/10.1128/aac.00918-12.
Hitchon, Carol A., Xiaobo Meng, Hani S. El Gabalawy y Linda Larcombe. "Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis". RMD Open 5, n.º 1 (abril de 2019): e000874. http://dx.doi.org/10.1136/rmdopen-2018-000874.
Chen, Xi, Xianqiong Zou, Guangying Qi, Ying Tang, Yong Guo, Jia Si y Lihua Liang. "Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer". Cellular Physiology and Biochemistry 47, n.º 3 (2018): 1060–73. http://dx.doi.org/10.1159/000490183.
Turner, Jeffrey, Yoon Cho, Nhu-Nguyen Dinh, Alan J. Waring y Robert I. Lehrer. "Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils". Antimicrobial Agents and Chemotherapy 42, n.º 9 (1 de septiembre de 1998): 2206–14. http://dx.doi.org/10.1128/aac.42.9.2206.
Deshpande, Dhruva, Mark Grieshober, Fanny Wondany, Fabian Gerbl, Reiner Noschka, Jens Michaelis y Steffen Stenger. "Super-Resolution Microscopy Reveals a Direct Interaction of Intracellular Mycobacterium tuberculosis with the Antimicrobial Peptide LL-37". International Journal of Molecular Sciences 21, n.º 18 (14 de septiembre de 2020): 6741. http://dx.doi.org/10.3390/ijms21186741.
Chawla, Himika, Parmita Kar, Soma Saha, Urvashi B. Singh, Nikhil Tandon y Goswami R. "Circulating Antimicrobial Peptide LL-37 Status in Type 1 Diabetes Mellitus and its Relation with Glycemic Control". Annals of the National Academy of Medical Sciences (India) 53, n.º 02 (abril de 2017): 066–72. http://dx.doi.org/10.1055/s-0040-1712747.
Raqib, Rubhana, Anna Ly, Evana Akhtar, Akhirunnesa Mily, Nandita Perumal, Abdullah Al-Mahmud, Rokeya Sultana Rekha, Abdullah Hel Baqui y Daniel E. Roth. "Prenatal vitamin D3supplementation suppresses LL-37 peptide expression inex vivoactivated neonatal macrophages but not their killing capacity". British Journal of Nutrition 112, n.º 6 (4 de agosto de 2014): 908–15. http://dx.doi.org/10.1017/s0007114514001512.
Kumagai, Yumi, Taisuke Murakami, Kuwahara-Arai, Toshiaki Iba, Johannes Reich y Isao Nagaoka. "Antimicrobial peptide LL-37 ameliorates a murine sepsis model via the induction of microvesicle release from neutrophils". Innate Immunity 26, n.º 7 (29 de junio de 2020): 565–79. http://dx.doi.org/10.1177/1753425920936754.
Lau, Y. Elaine, Annett Rozek, Monisha G. Scott, Danika L. Goosney, Donald J. Davidson y Robert E. W. Hancock. "Interaction and Cellular Localization of the Human Host Defense Peptide LL-37 with Lung Epithelial Cells". Infection and Immunity 73, n.º 1 (enero de 2005): 583–91. http://dx.doi.org/10.1128/iai.73.1.583-591.2005.
Shaykhiev, Renat, Christoph Beißwenger, Kerstin Kändler, Judith Senske, Annette Püchner, Thomas Damm, Jürgen Behr y Robert Bals. "Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure". American Journal of Physiology-Lung Cellular and Molecular Physiology 289, n.º 5 (noviembre de 2005): L842—L848. http://dx.doi.org/10.1152/ajplung.00286.2004.
Overhage, Joerg, Andrea Campisano, Manjeet Bains, Ellen C. W. Torfs, Bernd H. A. Rehm y Robert E. W. Hancock. "Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation". Infection and Immunity 76, n.º 9 (30 de junio de 2008): 4176–82. http://dx.doi.org/10.1128/iai.00318-08.
Rosen, Graciela, Michael N. Sela y Gilad Bachrach. "The Antibacterial Activity of LL-37 against Treponema denticola Is Dentilisin Protease Independent and Facilitated by the Major Outer Sheath Protein Virulence Factor". Infection and Immunity 80, n.º 3 (19 de diciembre de 2011): 1107–14. http://dx.doi.org/10.1128/iai.05903-11.
Noore, Jabeen, Adly Noore y Bingyun Li. "Cationic Antimicrobial Peptide LL-37 Is Effective against both Extra- and Intracellular Staphylococcus aureus". Antimicrobial Agents and Chemotherapy 57, n.º 3 (28 de diciembre de 2012): 1283–90. http://dx.doi.org/10.1128/aac.01650-12.
Yason, John Anthony, Sitara Swarna Rao Ajjampur y Kevin Shyong Wei Tan. "Blastocystis Isolate B Exhibits Multiple Modes of Resistance against Antimicrobial Peptide LL-37". Infection and Immunity 84, n.º 8 (23 de mayo de 2016): 2220–32. http://dx.doi.org/10.1128/iai.00339-16.
Tripathi, Shweta, Tesfaldet Tecle, Anamika Verma, Erika Crouch, Mitchell White y Kevan L. Hartshorn. "The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins". Journal of General Virology 94, n.º 1 (1 de enero de 2013): 40–49. http://dx.doi.org/10.1099/vir.0.045013-0.
OREN, Ziv, Jeffrey C. LERMAN, Gudmundur H. GUDMUNDSSON, Birgitta AGERBERTH y Yechiel SHAI. "Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity". Biochemical Journal 341, n.º 3 (26 de julio de 1999): 501–13. http://dx.doi.org/10.1042/bj3410501.
Jones, Allison, Miriam Geörg, Lisa Maudsdotter y Ann-Beth Jonsson. "Endotoxin, Capsule, and Bacterial Attachment Contribute to Neisseria meningitidis Resistance to the Human Antimicrobial Peptide LL-37". Journal of Bacteriology 191, n.º 12 (17 de abril de 2009): 3861–68. http://dx.doi.org/10.1128/jb.01313-08.
Johansson, Linda, Pontus Thulin, Parham Sendi, Erika Hertzén, Adam Linder, Per Åkesson, Donald E. Low, Birgitta Agerberth y Anna Norrby-Teglund. "Cathelicidin LL-37 in Severe Streptococcus pyogenes Soft Tissue Infections in Humans". Infection and Immunity 76, n.º 8 (19 de mayo de 2008): 3399–404. http://dx.doi.org/10.1128/iai.01392-07.
Nagaoka, Isao, Hiroshi Tamura y Johannes Reich. "Therapeutic Potential of Cathelicidin Peptide LL-37, an Antimicrobial Agent, in a Murine Sepsis Model". International Journal of Molecular Sciences 21, n.º 17 (19 de agosto de 2020): 5973. http://dx.doi.org/10.3390/ijms21175973.
Zeth, Kornelius y Enea Sancho-Vaello. "Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures". International Journal of Molecular Sciences 22, n.º 10 (14 de mayo de 2021): 5200. http://dx.doi.org/10.3390/ijms22105200.
Hase, Koji, Lars Eckmann, John D. Leopard, Nissi Varki y Martin F. Kagnoff. "Cell Differentiation Is a Key Determinant of Cathelicidin LL-37/Human Cationic Antimicrobial Protein 18 Expression by Human Colon Epithelium". Infection and Immunity 70, n.º 2 (febrero de 2002): 953–063. http://dx.doi.org/10.1128/iai.70.2.953-963.2002.
Bryzek, Danuta, Anna Golda, Joanna Budziaszek, Dominik Kowalczyk, Alicia Wong, Ewa Bielecka, Priyanka Shakamuri et al. "Citrullination-Resistant LL-37 Is a Potent Antimicrobial Agent in the Inflammatory Environment High in Arginine Deiminase Activity". International Journal of Molecular Sciences 21, n.º 23 (30 de noviembre de 2020): 9126. http://dx.doi.org/10.3390/ijms21239126.
Björstad, Åse, Galia Askarieh, Kelly L. Brown, Karin Christenson, Huamei Forsman, Karin Önnheim, Hsin-Ni Li et al. "The Host Defense Peptide LL-37 Selectively Permeabilizes Apoptotic Leukocytes". Antimicrobial Agents and Chemotherapy 53, n.º 3 (15 de diciembre de 2008): 1027–38. http://dx.doi.org/10.1128/aac.01310-08.
Zhang, Yingxia, Jayaram Lakshmaiah Narayana, Qianhui Wu, Xiangli Dang y Guangshun Wang. "Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37". Pharmaceuticals 14, n.º 12 (30 de noviembre de 2021): 1245. http://dx.doi.org/10.3390/ph14121245.